| Full Name | Ashley Deters |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 4 Arnold Mall, Arnold, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215481445 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 2016016860 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ashley Deters, 4 Arnold Mall, Arnold, MO 63010-2223 Ph: (636) 282-0125 | Ashley Deters, 4 Arnold Mall, Arnold, MO 63010-2223 Ph: (636) 282-0125 |
News Archive
For people with cancer, the oral blood thinner apixaban is at least as effective as dalteparin, a low molecular weight heparin given by injection, in preventing a repeat venous thromboembolism (VTE), or blood clot, with no excess in major bleeding events, according to Phase 3 trial results presented at the American College of Cardiology's Annual Scientific Session Together with World Congress of Cardiology.
The state media in China says that a mysterious disease has now killed 17 farm workers and left 41 others sick, in southwest China, after they handled sick or dead livestock.
The case of Sen. Edward Kennedy (D-Mass.), who has been diagnosed with brain cancer, is "identical from a regulatory standpoint to the plight of hundreds of thousands of other Americans" and "shouts to the heavens the humane necessity of urgent reform in the drug approval process to make it work better for people who have serious and terminal diseases," according to a Wall Street Journal opinion piece by Steven Walker and Ronald Trowbridge, chief adviser and adjunct scholar, respectively, of the Abigail Alliance for Better Access to Developmental Drugs.
Today the U.S. Food and Drug Administration granted approval for Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received one to three prior medications.
MAP Pharmaceuticals, Inc. today announced new data from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX orally inhaled migraine therapy showing low recurrence rates with LEVADEX. Eight additional analyses from the LEVADEX program also will be presented during the 2010 European Headache and Migraine Trust International Congress (EHMTIC) in Nice, France.
› Verified 4 days ago
Tessa Dickinson, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3488 Jeffco Blvd Ste 102, Arnold, MO 63010 Phone: 636-464-5439 Fax: 636-464-5438 | |
Mrs. Jane E Lackner, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4 Arnold Mall, Arnold, MO 63010 Phone: 636-282-0056 Fax: 636-282-0057 | |
Ms. Laura Dunn, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3488 Jeffco Blvd Ste 102, Arnold, MO 63010 Phone: 636-464-5439 | |
Brittany Nicole Hettick, MOT, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3488 Jeffco Blvd Ste 102, Arnold, MO 63010 Phone: 464-636-5439 | |
Ms. Kathryn English Petri, OT/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3488 Jeffco Blvd Ste 102, Arnold, MO 63010 Phone: 636-464-5439 Fax: 636-464-5438 | |
Mrs. Andrea Elizabeth Horsford, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1101 W Outer 21 Rd, Arnold, MO 63010 Phone: 636-296-9200 | |
Mrs. Heather Milford, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3488 Jeffco Blvd Ste 103a, Arnold, MO 63010 Phone: 636-464-5439 |